Conditions: Constipation-Predominant Irritable Bowel Syndrome
Keywords: Mosapride Irritable Bowel Syndrome Constipation
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 41
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether Mosapride, an agent which acts on serotonin receptors in the gastrointestinal tract, is effective in the treatment of constipation-predominant irritable bowel syndrome (C-IBS).

Detailed description:

Arms:
arm 1: Mosapride arm 2: Placebo

Interventions: intervention 1: Mosapride Citrate intervention 2: Placebo
Intervention descriptions: intervention 1: One 5 mg tablet taken orally three times per day (15 min before meals) for 8 weeks. intervention 2: One tablet (identical in shape and form to the actual drug) taken orally three times per day (15 min before meals) for 8 weeks.

Protocol document: